Octreotide: A Long-Acting Somatostatin Analog
- 1 October 1990
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 300 (4) , 267-273
- https://doi.org/10.1097/00000441-199010000-00011
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Treatment of 27 Postoperative Enterocutaneous Fistulas with the Long Half-life Somatostatin Analogue SMS 201–995Annals of Surgery, 1989
- Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin AnalogueNew England Journal of Medicine, 1987
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1985
- Rapid Reversal of Carcinoid Crisis with a Somatostatin AnalogueNew England Journal of Medicine, 1985
- LONG-ACTING AND SELECTIVE SUPPRESSION OF GROWTH HORMONE SECRETION BY SOMATOSTATIN ANALOGUE SMS 201-995 IN ACROMEGALYThe Lancet, 1984
- SomatostatinNew England Journal of Medicine, 1983
- Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture.Journal of Clinical Investigation, 1982
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982